Live Breaking News & Updates on மைக்கேல் தாசே

Stay updated with breaking news from மைக்கேல் தாசே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Depression Disconnect: New Survey Finds Most People with Depression Feel Deeply Misunderstood


(NAPSI) A new nationwide poll, the GeneSight Mental Health Monitor, has found more than 8 in 10 people diagnosed with depression say life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment. 
 
This is important news about a serious disease affecting more than 17 million Americans each year, according to the National Institute of Mental Health. 
 
“Depression is one of the most misunderstood disorders. When people misinterpret depressed patients as ‘lazy’ or ‘dramatic,’ they are vastly underestimating and misunderstanding the debilitating symptoms of major depressive disorder,” said Mark Pollack, M.D., chief medical officer for the GeneSight test at Myriad Genetics.  ....

United States , National Institute Of Mental Health , Bipolar Support Alliance , Corporal Michaelj Crescenz Va Medical Center , Mental Health Month , Genesight Mental Health , Perelman School Of Medicine , Genesight Mental Health Monitor , National Institute , Mark Pollack , Loved Ones , Michael Thase , Perelman School , Corporal Michael , Depression Treatment May , Depression Disconnect , ஒன்றுபட்டது மாநிலங்களில் , தேசிய நிறுவனம் ஆஃப் மன ஆரோக்கியம் , இருமுனை ஆதரவு கூட்டணி , மன ஆரோக்கியம் மாதம் , பெரல்மேன் பள்ளி ஆஃப் மருந்து , தேசிய நிறுவனம் , குறி போலேக் , நேசித்தேன் ஒன்று , மைக்கேல் தாசே , பெரல்மேன் பள்ளி ,

Depression disconnect: Survey finds people with depression feel misunderstood


A new nationwide poll, the GeneSight Mental Health Monitor, has found more than eight in 10 people diagnosed with depression say life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment.
Depression is a serious disease affecting more than 17 million Americans each year, according to the National Institute of Mental Health.
“Depression is one of the most misunderstood disorders. When people misinterpret depressed patients as ‘lazy’ or ‘dramatic,’ they are vastly underestimating and misunderstanding the debilitating symptoms of major depressive disorder,” Dr. Mark Pollack, chief medical officer for the GeneSight test at Myriad Genetics, said in a press release. ....

United States , National Institute Of Mental Health , Bipolar Support Alliance , Mental Health Month , Michaelj Crescenz Va Medical Center , Genesight Mental Health , Perelman School Of Medicine , Genesight Mental Health Monitor , National Institute , Mark Pollack , Myriad Genetics , Michael Thase , Perelman School , ஒன்றுபட்டது மாநிலங்களில் , தேசிய நிறுவனம் ஆஃப் மன ஆரோக்கியம் , இருமுனை ஆதரவு கூட்டணி , மன ஆரோக்கியம் மாதம் , பெரல்மேன் பள்ளி ஆஃப் மருந்து , தேசிய நிறுவனம் , குறி போலேக் , எண்ணற்ற ஜெநெடிக்ஸ் , மைக்கேல் தாசே , பெரல்மேன் பள்ளி ,

Depression Disconnect: New Survey Finds Most People with Depression Feel Deeply Misunderstood


(NAPSI)—A new nationwide poll, the GeneSight Mental Health Monitor, has found more than 8 in 10 people diagnosed with depression say life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment. 
This is important news about a serious disease affecting more than 17 million Americans each year, according to the National Institute of Mental Health. 
“Depression is one of the most misunderstood disorders. When people misinterpret depressed patients as ‘lazy’ or ‘dramatic,’ they are vastly underestimating and misunderstanding the debilitating symptoms of major depressive disorder,” said Mark Pollack, M.D., chief medical officer for the GeneSight test at Myriad Genetics.  ....

United States , National Institute Of Mental Health , Bipolar Support Alliance , Corporal Michaelj Crescenz Va Medical Center , Mental Health Month , Genesight Mental Health , Perelman School Of Medicine , Genesight Mental Health Monitor , National Institute , Mark Pollack , Loved Ones , Michael Thase , Perelman School , Corporal Michael , Depression Treatment May , Depression Disconnect , ஒன்றுபட்டது மாநிலங்களில் , தேசிய நிறுவனம் ஆஃப் மன ஆரோக்கியம் , இருமுனை ஆதரவு கூட்டணி , மன ஆரோக்கியம் மாதம் , பெரல்மேன் பள்ளி ஆஃப் மருந்து , தேசிய நிறுவனம் , குறி போலேக் , நேசித்தேன் ஒன்று , மைக்கேல் தாசே , பெரல்மேன் பள்ளி ,

NIMH » Questions and Answers about the NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study — Background


January 2006
1. What is the STAR D study?
A. The Sequenced Treatment Alternatives to Relieve Depression (STAR D) Study, funded by the NIH National Institute of Mental Health, is a nationwide public health clinical trial. The purpose of the trial is to determine the effectiveness of different treatments for people with Major Depressive Disorder (MDD) who have not responded to initial treatment with an antidepressant. This is the largest and longest study ever done to evaluate depression treatment. Over a seven-year period, the study enrolled more than 4,000 outpatients, aged 18-75 years. The participants were people who came to their doctors for care and who had other psychiatric and medical conditions like those regularly seen in typical clinical practices (see Ref 1). Patients from both mental health (specialty care) and non-mental health (primary medical care) practices in diverse racial, ethnic, and socioeconomic populations were enrolled in the study. ....

United States , University Of Texas Southwestern Medical Center , University Of Texas , Andrew Leuchter , Buspirone Buspar , Sidney Zisook , Richard Shelton , William Gilmer , Brad Gaynes , Melanie Biggs , Jonathan Alpert , Fred Quitkin , Tranylcypromine Parnate , Madhukar Trivedi , Susan Kornstein , Stephen Wisniewski , Robert Golden , Mustafa Husain , Jeff Mitchell , Sheldon Preskorn , Citalopram Celexa , Edward Friedman , Andrew Nierenberg , Steven Hollon , Nortriptyline Pamelor , Diane Stegman ,